Modulation by NADPH oxidase of the chronic cardiovascular and autonomic interaction between cyclosporine and NSAIDs in female rats

European Journal of Pharmacology

Volumn 806, Issue , 2017, Pages 96-104

  El Yazbi, Ahmed F ^a,b   Ibrahim, Karim S ^a   El Gowelli, Hanan M ^a   El Deeb, Nevine M ^c   El Mas, Mahmoud M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Blood pressure; Cyclosporine; Heart rate variability; NSAIDs; Oxidative stress

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOSPORIN; DICLOFENAC; DIPHENYLIODONIUM SALT; NONSTEROID ANTIINFLAMMATORY AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RHO KINASE; CYCLOOXYGENASE 2 INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC STRUCTURAL DAMAGE; CARDIOTOXICITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME REGULATION; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE FUNCTION; HEART RATE VARIABILITY; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HISTOPATHOLOGY; ISOVOLUMIC RELAXATION TIME; MEAN ARTERIAL PRESSURE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; TIME SERIES ANALYSIS; UPREGULATION; ANIMAL; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; DRUG EFFECTS; DRUG INTERACTION; METABOLISM; PHYSIOLOGY; TIME FACTOR; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; HEMODYNAMICS; NADPH OXIDASES; RATS; RATS, WISTAR; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 85017439297     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2017.04.016     Document Type: Article

References (56)

1. Altman, R.D., Perez, G.O., Sfakianakis, G.N., Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis. Am. J. Med. 93 (1992), 396–402.
2. Ardell, J.L., Rajendran, P.S., Nier, H.A., KenKnight, B.H., Armour, J.A., Central-peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac function. Am. J. Physiol. Heart Circ. Physiol. 309 (2015), H1740–H1752.
3. Bernardi, L., Keller, F., Sanders, M., Reddy, P.S., Griffith, B., Meno, F., Pinsky, M.R., Respiratory sinus arrhythmia in the denervated human heart. J. Appl. Physiol. (Bethesda, Md.: 1985) 67 (1989), 1447–1455.
4. Borer, K.E., Bailey, S.R., Harris, P.A., Elliott, J., Contractile responses of isolated equine digital arteries under hypoxic or hyperoxic conditions in vitro: role of reactive oxygen species and Rho kinase. J. Vet. Pharmacol. Ther. 36 (2013), 267–274.
5. Capone, M.L., Tacconelli, S., Rodriguez, L.G., Patrignani, P., NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population. Pharmacol. Rep. 62 (2010), 530–535.
6. Chuang, H.C., Hsueh, T.W., Chang, C.C., Hwang, J.S., Chuang, K.J., Yan, Y.H., Cheng, T.J., Nickel-regulated heart rate variability: the roles of oxidative stress and inflammation. Toxicol. Appl. Pharmacol. 266 (2013), 298–306.
7. Cunha, N.V., de Abreu, S.B., Panis, C., Grassiolli, S., Guarnier, F.A., Cecchini, R., Mazzuco, T.L., Pinge-Filho, P., Martins-Pinge, M.C., Cox-2 inhibition attenuates cardiovascular and inflammatory aspects in monosodium glutamate-induced obese rats. Life Sci. 87 (2010), 375–381.
8. Ding, W.Y., Ti, Y., Wang, J., Wang, Z.H., Xie, G.L., Shang, Y.Y., Tang, M.X., Zhang, Y., Zhang, W., Zhong, M., Prostaglandin F2alpha facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor/protein kinase C/Rho kinase pathway independent of transforming growth factor beta1. Int. J. Biochem. Cell Biol. 44 (2012), 1031–1039.
9. Djamali, A., Reese, S., Hafez, O., Vidyasagar, A., Jacobson, L., Swain, W., Kolehmainen, C., Huang, L., Wilson, N.A., Torrealba, J.R., Nox2 is a mediator of chronic CsA nephrotoxicity. Am. J. Transplant.: Off. J. Am. Soc. Transplant. Am. Soc. Transplant. Surg. 12 (2012), 1997–2007.
10. El-Gowelli, H.M., Helmy, M.W., Ali, R.M., El-Mas, M.M., Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-beta1/IL-2/COX-2/endothelin ET(B) receptor cascade. Toxicol. Appl. Pharmacol. 275 (2014), 88–95.
11. el-Mas, M.M., Abdel-Rahman, A.A., Contrasting effects of urethane, ketamine, and thiopental anesthesia on ethanol-clonidine hemodynamic interaction. Alcohol. Clin. Exp. Res. 21 (1997), 19–27.
12. El-Mas, M.M., Abdel-Rahman, A.A., Role of cardiac output in ethanol-evoked attenuation of centrally mediated hypotension in conscious rats. Hypertension 30 (1997), 288–294.
13. El-Mas, M.M., Abdel-Rahman, A.A., Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 288 (1999), 455–462.
14. El-Mas, M.M., Abdel-Rahman, A.A., Longitudinal studies on the effect of hypertension on circadian hemodynamic and autonomic rhythms in telemetered rats. Life Sci. 76 (2005), 901–915.
15. El-Mas, M.M., Afify, E.A., Omar, A.G., Sharabi, F.M., Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control. J. Pharmacol. Exp. Ther. 301 (2002), 346–354.
16. El-Mas, M.M., Mohy El-Din, M.M., Helmy, M.M., Omar, A.G., Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats. Eur. J. Pharmacol. 694 (2012), 82–88.
17. El-Mas, M.M., Helmy, M.W., Ali, R.M., El-Gowelli, H.M., Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling. Toxicol. Appl. Pharmacol. 284 (2015), 1–7.
18. El-Yazbi, A.F., Johnson, R.P., Walsh, E.J., Takeya, K., Walsh, M.P., Cole, W.C., Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries. J. Physiol. 588 (2010), 1747–1762.
19. El-Yazbi, A.F., Abd-Elrahman, K.S., Moreno-Dominguez, A., PKC-mediated cerebral vasoconstriction: role of myosin light chain phosphorylation versus actin cytoskeleton reorganization. Biochem. Pharmacol. 95 (2015), 263–278.
20. Farkouh, M.E., Greenberg, B.P., An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am. J. Cardiol. 103 (2009), 1227–1237.
21. Fraser, A.D., van Kuijk, A.W., Westhovens, R., Karim, Z., Wakefield, R., Gerards, A.H., Landewe, R., Steinfeld, S.D., Emery, P., Dijkmans, B.A., Veale, D.J., A randomised, double blind, placebo controlled, multicentre trial of combination therapy with methotrexate plus ciclosporin in patients with active psoriatic arthritis. Ann. Rheum. Dis. 64 (2005), 859–864.
22. Gossec, L., Smolen, J.S., European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update. 75 (2016), 499–510.
23. Grieve, D.J., Byrne, J.A., Siva, A., Layland, J., Johar, S., Cave, A.C., Shah, A.M., Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J. Am. Coll. Cardiol. 47 (2006), 817–826.
24. Helmy, M.W., El-Gowelli, H.M., Ali, R.M., El-Mas, M.M., Endothelin ETA receptor/lipid peroxides/COX-2/TGF-beta1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. Br. J. Pharmacol. 172 (2015), 4291–4302.
25. Ibrahim, K., El-Yazbi, A., El-Gowelli, H., El-Mas, M., Divergent effects for celecoxib and diclofenac on hemodynamic and left ventricular actions of cyclosporine in female rats. FASEB J., 2015, 29.
26. Ibrahim, K.S., El-Yazbi, A.F., El-Gowelli, H.M., El-Mas, M.M., Opposite modulatory effects of selective and non-selective cyclooxygenase inhibition on cardiovascular and autonomic consequences of cyclosporine in female rats. Basic Clin. Pharmacol. Toxicol., 2017.
27. Janssen, P.M., Zeitz, O., Keweloh, B., Siegel, U., Maier, L.S., Barckhausen, P., Pieske, B., Prestle, J., Lehnart, S.E., Hasenfuss, G., Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium. Cardiovasc. Res. 47 (2000), 99–107.
28. Johnson, R.P., El-Yazbi, A.F., Takeya, K., Walsh, E.J., Walsh, M.P., Cole, W.C., Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J. Physiol. 587 (2009), 2537–2553.
29. Kato, M., Nishida, S., Kitasato, H., Sakata, N., Kawai, S., Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J. Pharm. Pharmacol. 53 (2001), 1679–1685.
30. Kleiger, R.E., Stein, P.K., Bigger, J.T. Jr., Heart rate variability: measurement and clinical utility. Ann. Noninvasive Electrocardiol.: Off. J. Int. Soc. Holter Noninvasive Electrocardiol., Inc. 10 (2005), 88–101.
31. Kovarik, J.M., Mueller, E.A., Gerbeau, C., Tarral, A., Francheteau, P., Guerret, M., Cyclosporine and nonsteroidal antiinflammatory drugs: exploring potential drug interactions and their implications for the treatment of rheumatoid arthritis. J. Clin. Pharmacol. 37 (1997), 336–343.
32. Lee, M.S., Chang, C.H., Lin, R.Y., Lai, M.S., Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan. Pharmacoepidemiol. Drug Saf. 25 (2016), 133–140.
33. Looi, Y.H., Grieve, D.J., Siva, A., Walker, S.J., Anilkumar, N., Cave, A.C., Marber, M., Monaghan, M.J., Shah, A.M., Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51 (2008), 319–325.
34. LoVecchio, F.A., Goltz, H.R., Atrial fibrillation following acute overdose with oral cyclosporine. Ann. Pharmacother., 34, 2000, 405.
35. Martinez, L.L., Oliveira, M.A., Miguel, A.S., Rastelli, V.M., Walber, J., Cruz, M.C., Tostes, R.C., Carvalho, M.H., Nigro, D., Fortes, Z.B., Enalapril interferes with the effect of diclofenac on leucocyte-endothelium interaction in hypertensive rats. J. Cardiovasc. Pharmacol. 43 (2004), 258–265.
36. Martinez, L.L., Oliveira, M.A., Miguel, A.S., Rastelli, V.M., Cruz, J.W., Tostes, R.C., Carvalho, M.H., Nigro, D., Fortes, Z.B., Losartan attenuates the antimigratory effect of diclofenac in spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 46 (2005), 190–199.
37. Matsubara, H., Takaki, M., Yasuhara, S., Araki, J., Suga, H., Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better Altern. Expon. Time Constant Circ. 92 (1995), 2318–2326.
38. Matsuda, S., Koyasu, S., Mechanisms of action of cyclosporine. Immunopharmacology 47 (2000), 119–125.
39. Moreno-Dominguez, A., El-Yazbi, A.F., Zhu, H.L., Colinas, O., Zhong, X.Z., Walsh, E.J., Cole, D.M., Kargacin, G.J., Walsh, M.P., Cole, W.C., Cytoskeletal reorganization evoked by Rho-associated kinase- and protein kinase C-catalyzed phosphorylation of cofilin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries. J. Biol. Chem. 289 (2014), 20939–20952.
40. Muscara, M.N., McKnight, W., Asfaha, S., Wallace, J.L., Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br. J. Pharmacol. 129 (2000), 681–686.
41. Nair, A.B., Jacob, S., A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharm. 7 (2016), 27–31.
42. Nasser, S.A., Elmallah, A.I., Sabra, R., Khedr, M.M., El-Din, M.M., El-Mas, M.M., Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions. Eur. J. Pharmacol. 727 (2014), 52–59.
43. Navarro, J.F., Mora, C., Marcen, R., Teruel, J.L., Gamez, C., Jimenez, J.J., Orofino, L., Ortuno, J., Acute cardiovascular effects of intravenous cyclosporine. Int. Urol. Nephrol. 28 (1996), 575–581.
44. Omar, A.G., El-Mas, M.M., Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats. Cardiovasc. Drugs Ther. / Spons. Int. Soc. Cardiovasc. Pharmacother. 18 (2004), 461–468.
45. Oriji, G.K., Keiser, H.R., Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32 (1998), 849–855.
46. Park, J.W., Park, C.H., Kim, I.J., Bae, E.H., Ma, S.K., Lee, J.U., Kim, S.W., Rho kinase inhibition by fasudil attenuates cyclosporine-induced kidney injury. J. Pharmacol. Exp. Ther. 338 (2011), 271–279.
47. Semeniuk, L.M., Severson, D.L., Kryski, A.J., Swirp, S.L., Molkentin, J.D., Duff, H.J., Time-dependent systolic and diastolic function in mice overexpressing calcineurin. Am. J. Physiol. Heart Circ. Physiol. 284 (2003), H425–H430.
48. Stein, P.K., Bosner, M.S., Kleiger, R.E., Conger, B.M., Heart rate variability: a measure of cardiac autonomic tone. Am. Heart J. 127 (1994), 1376–1381.
49. Sudano, I., Flammer, A.J., Roas, S., Enseleit, F., Noll, G., Ruschitzka, F., Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension. Curr. Hypertens. Rep. 14 (2012), 304–309.
50. Tavares, P., Reis, F., Ribeiro, C.A., Teixeira, F., Cardiovascular effects of cyclosporin treatment in an experimental model. Rev. Port. De. Cardiol.: orgao Of. da Soc. Port. De. Cardiol. = Port. J. Cardiol.: Off. J. Port. Soc. Cardiol. 21 (2002), 141–155.
51. Therapondos, G., Flapan, A.D., Dollinger, M.M., Garden, O.J., Plevris, J.N., Hayes, P.C., Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. Liver Transplant.: Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc. 8 (2002), 690–700.
52. Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P.M., Egger, M., Juni, P., Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ (Clin. Res. Ed.), 342, 2011, c7086.
53. Vanoli, E., De Ferrari, G.M., Stramba-Badiale, M., Hull, S.S. Jr., Foreman, R.D., Schwartz, P.J., Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ. Res. 68 (1991), 1471–1481.
54. Wang, Y.X., Pang, C.C., Functional integrity of the central and sympathetic nervous systems is a prerequisite for pressor and tachycardic effects of diphenyleneiodonium, a novel inhibitor of nitric oxide synthase. J. Pharmacol. Exp. Ther. 265 (1993), 263–272.
55. Wesselman, J.P., Kuijs, R., Hermans, J.J., Janssen, G.M., Fazzi, G.E., van Essen, H., Evelo, C.T., Struijker-Boudier, H.A., De Mey, J.G., Role of the Rhoa/Rho kinase system in flow-related remodeling of rat mesenteric small arteries in vivo. J. Vasc. Res. 41 (2004), 277–290.
56. Zheng, C., Li, M., Inagaki, M., Kawada, T., Sunagawa, K., Sugimachi, M., 2005. Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conference proceedings: … Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference 7, pp. 7072–7075.